When 30-year-old HR professional Rekha Verma (name changed) was diagnosed with breast cancer in 2012, she couldn’t afford ‘wonder drug’ trastuzumab.
She prayed that surgery, chemotherapy and radiotherapy would be enough.
Last month, she relapsed and was once again advised to use trastuzumab along with chemotherapy. The drug’s price had halved since 2012 and cheaper versions were also available.
Still, they were too expensive for Verma— her family’s combined monthly income was at least `50,000 short of the monthly treatment cost and trastuzumab’s price accounted for a major chunk. Her medical insurance didn’t cover this drug, she said...Read more
Source web page: Economic Times